Showing results (1661-1670 of 4,206) with videos related to
Sort By:
Pageof 421
Current Topics in Medicinal Chemistry|September 24, 2005
P38 MAP kinase inhibitors: evolution of imidazole-based and pyrido-pyrimidin-2-one lead classesSwaminathan R Natarajan, James B DohertyCurrent Topics in Medicinal Chemistry|February 20, 2007
Dual acting anti-inflammatory drugsS Leone, A Ottani, A BertoliniCurrent Topics in Medicinal Chemistry|February 20, 2007
Design of second generation phosphodiesterase 5 inhibitorsMichael J Palmer, Andrew S Bell, David N A Fox, et al.Current Topics in Medicinal Chemistry|February 20, 2007
Re-discovering PDE3 inhibitors--new opportunities for a long neglected targetPhilip E Thompson, Vincent Manganiello, Eva DegermanCurrent Topics in Medicinal Chemistry|February 3, 2007
Recent advances in alpha1-adrenoreceptor antagonists as pharmacological tools and therapeutic agentsMichela Rosini, Maria L Bolognesi, Dario Giardinà, et al.Current Topics in Medicinal Chemistry|February 3, 2007
Interest of alpha2-adrenergic agonists and antagonists in clinical practice: background, facts and perspectivesPierre-Antoine Crassous, Colette Denis, Hervé Paris, et al.Current Topics in Medicinal Chemistry|February 3, 2007
The in silico insights of alpha-adrenergic receptors over the last decade: methodological approaches and structural features of the 3D modelsAntonio Carrieri, Alessandra FanoCurrent Topics in Medicinal Chemistry|March 10, 2007
New tuberculosis drugs in developmentBarbara E LaughonCurrent Topics in Medicinal Chemistry|March 10, 2007
Nitrofurans as novel anti-tuberculosis agents: identification, development and evaluationRajendra P Tangallapally, Raghunandan Yendapally, AnTawan J Daniels, et al.Current Topics in Medicinal Chemistry|March 14, 2007
Aromatic heterocycle-based DPP-IV inhibitors: xanthines and related structural typesBruce G Szczepankiewicz, Ravi KurukulasuriyaPageof 421